- recruiting
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
This study looks at how new ways of classifying brain tumours (cIMPACT-NOW and 2021 WHO) help us understand treatment and what to expect. Researchers want to see if these new classifications group patients better and lead to clearer treatment guidelines for different types of brain tumours.
Austria · Belgium · France - active not recruitingPHASE1
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
This study is testing a new cancer vaccine called SurVaxM for children and young adults with specific types of brain tumours. It aims to train the body's immune system to find and destroy cancer cells that have a special protein.
United States · Canada - active not recruitingPHASE1
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
This study is testing a new immune cell therapy for children aged 1-21 with a brain tumour called ependymoma, if it has recurred or grown. It aims to see if it's safe, how well it works, and if it can be given in different hospitals across the UK.
United States · Canada